title: Insulin-like growth factor I as an angiogenic agent. In vivo and in vitro studies.
authors.affiliation: Department of Medicine, University of Florida College of Medicine, Gainesville 32610.
authors.forename: M B
authors.initials: MB
authors.lastname: Grant
authors.forename: R N
authors.initials: RN
authors.lastname: Mames
authors.forename: C
authors.initials: C
authors.lastname: Fitzgerald
authors.forename: E A
authors.initials: EA
authors.lastname: Ellis
authors.forename: S
authors.initials: S
authors.lastname: Caballero
authors.forename: N
authors.initials: N
authors.lastname: Chegini
authors.forename: J
authors.initials: J
authors.lastname: Guy
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002633:Chemotaxis / Q000187:drug effects; D003315:Cornea / Q000187:drug effects* / Q000473:pathology; D003692:Delayed-Action Preparations; D004343:Drug Implants; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D009389:Neovascularization, Pathologic; D011817:Rabbits; D011994:Recombinant Proteins / Q000494:pharmacology; D012171:Retinal Vessels / Q000166:cytology / Q000187:drug effects* / Q000473:pathology
chemical_list: D003692:Delayed-Action Preparations; D004343:Drug Implants; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I